A Randomised, Double-Blind, Phase 2 study of ALIMTA As First-Line Chemotherapy For Advanced Breast Cancer

  • Poole, Christopher (Principal Investigator)

Project Details

Short titleA Randomised, Double-Blind, Phase 2 study of ALIMTA As First-Line Chemotherapy For Advanced Breast Cancer
StatusFinished
Effective start/end date1/07/03 → 30/11/04

Funding

  • LILLY RESEARCH CENTRE LIMITED
View all
View less